Cure My Disease

Don't miss your cure!

 Log in / Sign up

New obesity drug MKP10241 enters human testing – food may change how it works

NCT ID NCT07098663

Recruiting now Knowledge-focused Sponsor: Mankind Pharma Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called MKP10241 in healthy people, people with obesity, and those with obesity plus type 2 diabetes. Researchers want to see if taking the drug with food changes how it works, and whether different doses are safe. About 68 participants will take either the drug or a placebo and be closely monitored for side effects. This is an early-phase study focused on safety and drug behavior, not on curing or treating the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FOOD EFFECT OBESITY SAFETY, AND TOLERABILITY TYPE 2 DIABETES MELLITUS (T2DM)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Veritus Research

    RECRUITING

    Bayswater, Victoria, 3153, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••